Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd stock ¥3.32, price ¥7.39, that is 55.1% below the price, quality 30 out of 100. Rating: strongly overvalued. Calculated from audited financials with 4 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
301126 · SHEFar too expensive (fair value 55% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 22, 2026.
How to read this chart
59‑month range ¥6.78 – ¥35.81 · fair‑value band ¥2.95 – ¥3.62 · the ¥7.39 price screens above the ¥3.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 22, 2026.
Every Wednesday you see whether Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products.
Show moreShow less
The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages, drinks, and probiotic beverages; and cleansing and care products.
In addition, it provides pharmaceutical logistics services; and operates reproductive hospitals. The company was formerly known as Hunan Tongjian Pharmacy CO., LTD and changed its name to Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd in August 2016.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd was founded in 2002 and is headquartered in Changsha, China.
Stock analysis
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) currently trades at ¥7.39, while our model-based Fair Value estimate is ¥3.32, 55% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥4.96 per share, and 0 of the 4 models we run sit above the ¥7.39 price.
Bear case: the Asset-Based group reads lowest at ¥0.94, and 4 of the 4 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥2.95 (bear) to ¥3.62 (bull), the price of ¥7.39 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd reported revenue of 5.1B CNY in FY2025 versus 2.6B CNY in FY2021, a compound +18.7%/yr. Reported net income was −242M CNY in FY2025.
Key figures
Market cap 1.5B CNY (≈ $228M) Micro · P/S ratio 0.30 · EPS (TTM) ¥-1.16 · Dividend yield 0.3% · Net margin −4.7% · Return on equity −12.7% · Return on assets (EBIT) 3.2% (5-year average) · Operating margin 1.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 49% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 18% fair-value upside, at −55%, 301126 screens richer than that median.
Fair Value models
All 4 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 55 stocks
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EV/EBITDA by industry
- Dividend yield by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| JD Health International Inc 6618 | HK$32.60 | HK$75.43 | +131% | vs 301126 |
| Yifeng Pharmacy Chain Co 603939 | ¥26.26 | ¥40.59 | +55% | vs 301126 |
| Yixintang Pharmaceutical Group 002727 | ¥12.87 | ¥18.92 | +47% | vs 301126 |
| DaShenLin Pharmaceutical Group 603233 | ¥20.58 | ¥25.52 | +24% | vs 301126 |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥11.35 | ¥13.41 | +18% | vs 301126 |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥14.37 | ¥15.81 | +10% | vs 301126 |
| DocMorris AG DOCM | CHF 18.53 | CHF 15.12 | −18% | vs 301126 |
| MedPlus Health Services Limited MEDPLUS | ₹603.95 | ₹393.15 | −35% | vs 301126 |
| ShuYu Civilian Pharmacy Corp 301017 | ¥9.83 | ¥5.91 | −40% | vs 301126 |
| Apotea AB APOTEA | kr 101.20 | kr 39.50 | −61% | vs 301126 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) overvalued or undervalued?
What is the fair value of 301126?
What is the quality score of 301126?
What is the price target for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd stock forecast for 2026?
What is the revenue of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
Does Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd pay a dividend?
How much is the dividend of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) and when is the ex-dividend date?
What is the intrinsic value of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
Is Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 301126?
How much is Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd worth?
What do the bullish and bearish scenarios say about 301126?
How solid is the balance sheet of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
How far is 301126 from its 52-week high?
Which stocks are comparable to Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd?
Is Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd stock attractive at the current price?
How is the fair value of 301126 calculated?
Is it still worth investing in stocks now?
What is the share price of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What should I pay attention to with Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd right now?
Key figures of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
How large is the market capitalisation of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the P/S ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What are the earnings per share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the dividend yield of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the net margin of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the return on equity of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the EBIT return on assets of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
What is the operating margin of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
How fast is revenue growing at Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
How fast are earnings growing at Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)?
How much free cash flow does Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) generate?
How much net debt does Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) carry?
Watch Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd in the live analysis
One click puts Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.